{
  "id": 1797,
  "text": "Patients were treated with a combination of EBRT and intracavitary brachytherapy.Concurrent chemotherapy consisted of cisplatin.The 5-year OS were $4 0 \\%$ for patients who underwent concurrent chemotherapy and extended field radiotherapy as compared to $1 8 \\%$ for patients who had extended field radiotherapy alone, with median survival of 29 months and 13 months, respectively.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Patients were treated with a combination of EBRT and intracavitary brachytherapy.Concurrent chemotherapy consisted of cisplatin.The 5-year OS were $4 0 \\%$ for patients who underwent concurrent chemotherapy and extended field radiotherapy as compared to $1 8 \\%$ for patients who had extended field radiotherapy alone, with median survival of 29 months and 13 months, respectively.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于接受同步化疗（顺铂）与全盆腔放疗（包括外照射和腔内近距离治疗）治疗的患者，其5年总体生存率为40%，而单独接受放疗的患者5年总体生存率仅为18%。两组患者的中位生存期分别为29个月和13个月。",
  "query": "对于接受同步化疗与全盆腔放疗治疗的患者，5年总体生存率与单独接受放疗的患者相比如何？两组的中位生存期分别是多少？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于接受同步化疗与全盆腔放疗治疗的患者，5年总体生存率与单独接受放疗的患者相比如何？两组的中位生存期分别是多少？\n\n<reference text>: Patients were treated with a combination of EBRT and intracavitary brachytherapy.Concurrent chemotherapy consisted of cisplatin.The 5-year OS were $4 0 \\%$ for patients who underwent concurrent chemotherapy and extended field radiotherapy as compared to $1 8 \\%$ for patients who had extended field radiotherapy alone, with median survival of 29 months and 13 months, respectively.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于接受同步化疗（顺铂）与全盆腔放疗（包括外照射和腔内近距离治疗）治疗的患者，其5年总体生存率为40%，而单独接受放疗的患者5年总体生存率仅为18%。两组患者的中位生存期分别为29个月和13个月。"
}